6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02236065 (ClinicalTrials.gov)	August 2014	8/9/2014	Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders	A Pilot Study of Combination Therapy of Allogeneic Umbilical Cord Blood and Granulocyte-colony Stimulating Factor for Patients With Brain Injury or Neurodegenerative Disorders	Brain Injury;Cerebral Palsy;Amyotrophic Lateral Sclerosis;Parkinson's Disease	Procedure: Umbilical cord blood therapy;Biological: Filgrastim	MinYoung Kim, M.D.	NULL	Completed	19 Years	75 Years	All	10	N/A	Korea, Republic of
2	NCT02018406 (ClinicalTrials.gov)	December 2013	30/10/2013	Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury		Neurological Diseases;Ischemic Stroke;Hemorrhagic Stroke;Cerebral Palsy;Atypical Parkinson Disease	Drug: Combination injection of EPO and G-CSF;Drug: Injection of normal saline	Yonsei University	NULL	Active, not recruiting	20 Years	N/A	All	16	Phase 1/Phase 2	Korea, Republic of
3	NCT01227681 (ClinicalTrials.gov)	June 2010	22/10/2010	Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease	A Double-Blind, Placebo-Control, Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease	Parkinson Disease	Drug: G-CSF;Drug: Placebo	Buddhist Tzu Chi General Hospital	NULL	Terminated	40 Years	65 Years	All	4	Phase 2	Taiwan